REGENEREX PHARMA, INC. (RGPX) › Cash & EquivalentsREGENEREX PHARMA, INC. (RGPX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $4.5K2011: $1.7K2012: $7.8K2013: $1572014: $1.3K2018: $1.7K2019: $88.5K2020: $5.5K2021: $6.9K2022: $2.6K2023: $1.1K2024: $3722025: $653.0K$653.0K2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$653.0K+175444.4%2024$372-67.2%2023$1.1K-57.0%2022$2.6K-61.8%2021$6.9K+26.4%2020$5.5K-93.8%2019$88.5K+5024.2%2018$1.7K—2014$1.3K+740.1%2013$157-98.0%2012$7.8K+369.8%2011$1.7K-63.5%2010$4.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share